Cosmo Pharmaceuticals N.V.

Informe acción SWX:COPN

Capitalización de mercado: CHF 1.0b

Cosmo Pharmaceuticals Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Giovanni Di Napoli

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOless than a year
Participación del CEOn/a
Permanencia media de la dirección3.8yrs
Promedio de permanencia en la Junta Directivaless than a year

Actualizaciones recientes de la dirección

Recent updates

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Mar 26
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Dec 01
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 29
Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Nov 24
We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

Mar 31
Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

May 20
Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

Apr 03
Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Mar 07
When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

CEO

Giovanni Di Napoli (50 yo)

less than a year

Permanencia

Mr. Giovanni Di Napoli is Chief Executive Officer and Director of Cosmo Pharmaceuticals N.V. from May 24, 2024. He was President of Gastrointestinal at Medtronic plc. He is an accomplished leader with an e...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Alessandro Della Cha
Executive Chairman18.8yrs€1.16msin datos
Niall Donnelly
Executive Director & CFO8.4yrssin datossin datos
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearsin datossin datos
Mauro Ajani
Founder & Non-Executive Director18.8yrs€400.00ksin datos
Marco Lecchi
Chief Operating Officer3.8yrssin datossin datos
Davide Malavasi
Qualified Person & Technical Director13.2yrssin datossin datos
Luigi Longo
Chief Scientific Officer2.6yrssin datossin datos
Hazel Winchester
Head of Investor Relations2.8yrssin datossin datos
Biagio Vigano
Chief People Officer3.8yrssin datossin datos
Roberto Villa
Chief Manufacturing Officer27.8yrssin datossin datos
Ngo Nhan
President of Cosmo Intelligent Medical Devicesno datasin datossin datos
Andrea Cherubini
SVP of Science4.8yrssin datossin datos

3.8yrs

Permanencia media

51.5yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de COPN se considera experimentado (3.8 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Alessandro Della Cha
Executive Chairman18.8yrs€1.16msin datos
Niall Donnelly
Executive Director & CFOless than a yearsin datossin datos
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearsin datossin datos
Mauro Ajani
Founder & Non-Executive Director18.8yrs€400.00ksin datos
William Sandborn
Member of Scientific Advisory Boardno datasin datossin datos
Geert D'Haens
Member of Scientific Advisory Boardno datasin datossin datos
Silvio Danese
Member of Scientific Advisory Boardno datasin datossin datos
Maria Roncarolo
Non-Executive Director12.6yrs€128.79ksin datos
Ralf Kiesslich
Member of Scientific Advisory Boardno datasin datossin datos
Robert Steffen
Member of Scientific Advisory Boardno datasin datossin datos
Silvana Perretta
Non-Executive Directorless than a yearsin datossin datos
John O'Dea
Non-Executive Directorless than a yearsin datossin datos

0.5yrs

Permanencia media

61yo

Promedio de edad

Junta con experiencia: La junta directiva de COPN no se considera experimentada (0.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.